NUC group n = 33(%) | Non-NUC group n = 43(%) | |
---|---|---|
Liver transplantation | 2(6.06%) | 0(0) |
Liver resection | 2(6.06%) | 1(2.33%) |
Liver resection+TACE | 2(6.06%) | 2(4.65%) |
TACE | 17(51.52%) | 2(4.65%) |
Ablation | 2(6.06%) | 0(0) |
TACE add ablation | 2(6.06%) | 0(0) |
Sorafenib | 0(0) | 1(2.32%) |
No treatment | 6(18.18%) | 37(86.04%) |